πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe β€” grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≀24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β€” use filters for patent-cliff planning.

Page 55 of 78

  1. US 7776337

    Bacteriocins and novel bacterial strains

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7776521

    Coronavirus isolated from humans

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7776883

    Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7771715

    Recombinant vector expressing multiple costimulatory molecules and uses thereof

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7771729

    Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7771956

    Method for detecting the presence of a phospholipid

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7767645

    SH2 domain binding inhibitors

    Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7763586

    Melanoma antigens and their use in diagnostic and therapeutic methods

    Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7763719

    Variants of humanized anti-carcinoma MAb CC49

    Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7763451

    Methods for preparing Bacillus anthracis protective antigen for use in vaccines

    Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7758855

    DNA promoters and anthrax vaccines

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7758876

    Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7759330

    21-substituted progesterone derivatives as new antiprogestational agents

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7759106

    Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E. coli

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7754420

    Methods of using cyanovirins to inhibit viral infection

    Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7754461

    Large-scale production of human serum butyrylcholinesterase as a bioscavenger

    Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7754676

    Defensin-antigen fusion proteins

    Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7754227

    Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

    Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7749984

    Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7749719

    Melanoma antigens and their use in diagnostic and therapeutic methods

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7749967

    Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7745144

    Peptides and their utility in modulation of behavior of cells expressing Ξ±3Ξ²1 integrins

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7745388

    Peptides for activation and inhibition of Ξ΄PKC

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7745212

    Melanoma antigens and their use in diagnostic and therapeutic methods

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7744902

    Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7741113

    Cell-specific molecule and method for importing DNA into osteoblast nuclei

    Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7741437

    P. ariasi polypeptides, p. perniciosus polypeptides and methods of use

    Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7741063

    Toxoplasma gondii oocyst protein

    Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7741431

    Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof

    Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7740889

    Bacteriocins and novel bacterial strains

    Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7736656

    Immunogenic compositions and vaccines for Ebola

    Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7731953

    Methods for use of TSLP and agonists and antagonists thereof

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7731971

    Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptides

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7731975

    Chimeric filovirus glycoprotein

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7731939

    Vaccine compositions and adjuvant

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7727514

    Compositions comprising a UV-absorbing chromophore

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7723500

    Immunostimulatory nucleic acid molecules

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7723311

    Delivery of bioactive substances to target cells

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7722889

    Plasmodium liver stage antigens

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7723096

    Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the agonist peptides

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7723022

    Immunostimulatory nucleic acid molecules

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7723111

    Activated dual specificity lymphocytes and their methods of use

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7718424

    AAV4 vector and uses thereof

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7718779

    Prophylactic and therapeutic monoclonal antibodies

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7718183

    Proteins with repetitive bacterial-Ig-like (big) domains present in Leptospira species

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7718196

    Rapamycin-resistant T cells and therapeutic uses thereof

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7713529

    Methods for treating and preventing infectious disease

    Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7709002

    Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes

    Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.